CDC asks all staff to return to office Sept. 15, five weeks after shooting at headquarters
A sign for the CDC sits outside of their facility at the Centers for Disease Control and Prevention Roybal campus ...
Tag: Biotech and Pharmaceuticals
Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott ...
FDA approves first-ever glucose monitoring system for weight loss from Signos
Woman with Signos wearable and appSource: SignosThe Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically ...
Viking Therapeutics shares fall 40% on disappointing obesity pill trial data
Shares of Viking Therapeutics fell 40% on Tuesday after the company released mid-stage trial data on its obesity pill that ...
FDA may pull authorization of Pfizer’s Covid vaccine for children under 5
A nurse prepares doses of the Pfizer vaccine during a COVID-19 vaccination event at Josephine's Southern Cooking in Chatham, Illinois, ...
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz, Administrator for ...
UnitedHealth says it is cooperating with DOJ investigations into Medicare billing practices
UnitedHealth Group revealed Thursday it is facing Department of Justice investigations over its Medicare billing practices, adding to a string ...
Weight loss drugs could be a gamechanger for women with a common hormonal disorder
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025.Shelby Knowles | Bloomberg | Getty ImagesFor well ...
Sarepta shares plunge 40% as future of its gene therapy appears at risk
Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, ...
Family offices ramp up deal-making in June with bets on biotech
Key PointsAfter a slow spring, investment firms of the ultra-rich made 60 direct investments in June, according to Fintrx.Family offices ...
